Equity / Investment · MENA · Announced 11 Nov 2026

Hikma Ventures → Rem3dy Health

Hikma Ventures made an undisclosed strategic investment in UK-based Rem3dy Health, maker of Nourished 3D-printed nutrition gummies, alongside Hikma's exclusive deal to sell the brand across MENA, starting in Saudi Arabia and the UAE.

Parties: Hikma Ventures (United Kingdom) → Rem3dy Health (United Kingdom)

Value
Undisclosed
Territory
MENA, initially Saudi Arabia and the United Arab Emirates (commercial agreement)
Therapeutic area
Consumer health
Asset
Nourished
Announced
11 Nov 2026

Our analysis

Why this matters

Hikma Ventures, the corporate venture arm of Hikma Pharmaceuticals, announced on 11 November 2026 a strategic investment in Rem3dy Health, a UK health technology company. The size of the stake and the amount were not disclosed. The investment comes on top of a commercial agreement, announced in late October, that makes Hikma the exclusive partner bringing Rem3dy's Nourished brand to consumers in the Middle East and North Africa, starting with Saudi Arabia and the UAE.

Rem3dy's patented 3D-printing platform combines up to seven precisely dosed active ingredients into one personalised gummy "stack". The company says it holds 29 patents. This is Hikma Ventures' first investment in health and wellness. It has backed more than 20 healthcare companies, mostly in digital health, connected devices, diagnostics and AI.

The full analysis is free to read with a work email on this page.

Source: Hikma press release

More deals involving Hikma Ventures or Rem3dy Health

Latest deals

All MENA deals → · All equity / investment deals → · Browse all emerging-market pharma deals →